Dr. Nauman Moazzam, MD

Dr. Moazzam practices at AdventHealth Avista in Louisville, Colorado, part of AdventHealth.

Dr. Moazzam's NPI, 1407812043, was assigned on April 22, 2006. Dr. Moazzam graduated from King Edward Medical University in 1999. Dr. Moazzam holds Colorado license 49295.

Dr. Moazzam's primary practice is AdventHealth Avista, at 100 Health Park Dr, Louisville, CO 80027 in Boulder County. The practice phone is (303) 673-1000.

Dr. Moazzam's primary practice is AdventHealth Avista in Louisville, Colorado, part of AdventHealth. Dr. Moazzam is also affiliated with CommonSpirit - St. Anthony Hospital. The medical group on file is Rocky Mountain Cancer Centers. Dmand AI also links Dr. Moazzam to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moazzam practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Moazzam's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Moazzam is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Moazzam's licenses on file in 2 states: Colorado and Minnesota.

CMS data shows 359,322 Medicare services from Dr. Moazzam across 95 procedure codes in 2024, for 989 Medicare patients. Medicare paid $3,084,605 for them. Every service was in an office.

CMS counts 989 Medicare patients who saw Dr. Moazzam in 2024. The largest group is 65 to 74, with 468 patients. 66% of them have high cholesterol, and 64% have high blood pressure. 11% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moazzam's median patient age at 72, with 47% women.

In 2024, Dr. Moazzam wrote 2,432 Medicare Part D claims for 530 patients. 78% of them were for generic drugs. CMS names the drug for 2,115 of them, across 45 drugs with 11 or more claims each, at $3,867,208 in total drug cost. In 2023, CMS named 2,293 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 73 out of 100 for Dr. Moazzam for performance year 2024, reported through an alternative payment model (APM). Dr. Moazzam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moazzam as offering telehealth.

Dmand AI links 2 papers to Dr. Moazzam, published from 2018 to 2019. Dr. Moazzam's most frequent co-authors are Mayer N. Fishman, MD, Ralph J. Hauke, MD and Martin Henner Voss, MD.

CMS Open Payments shows 321 general payments to Dr. Moazzam from 54 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 75% of the total. Janssen Pharmaceuticals, Inc paid the most, $21,915.

Dr. Moazzam graduated from King Edward Medical University in 1999.

Dr. Moazzam is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.